What is a stock summary page? Click here for an overview.
Business Description
Labcorp Holdings Inc
NAICS : 621511
SIC : 8071
ISIN : US50540R4092
Share Class Description:
LH: Ordinary SharesDescription
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.9 | |||||
| Debt-to-EBITDA | 4.02 | |||||
| Interest Coverage | 5.46 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.81 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.6 | |||||
| 3-Year EBITDA Growth Rate | -17.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13.7 | |||||
| 3-Year FCF Growth Rate | -22.2 | |||||
| 3-Year Book Growth Rate | -4.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 10.11 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.44 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.05 | |||||
| 9-Day RSI | 36.64 | |||||
| 14-Day RSI | 40.69 | |||||
| 3-1 Month Momentum % | 6.24 | |||||
| 6-1 Month Momentum % | 11.47 | |||||
| 12-1 Month Momentum % | 17.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.44 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 18.42 | |||||
| Days Sales Outstanding | 56.61 | |||||
| Days Payable | 29.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.2 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| Forward Dividend Yield % | 1.2 | |||||
| 5-Year Yield-on-Cost % | 1.2 | |||||
| 3-Year Average Share Buyback Ratio | 3.6 | |||||
| Shareholder Yield % | -0.23 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.86 | |||||
| Operating Margin % | 8.75 | |||||
| Net Margin % | 5.74 | |||||
| FCF Margin % | 8.42 | |||||
| ROE % | 9.31 | |||||
| ROA % | 4.29 | |||||
| ROIC % | 5.7 | |||||
| 3-Year ROIIC % | 73.65 | |||||
| ROC (Joel Greenblatt) % | 27.76 | |||||
| ROCE % | 8.46 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.16 | |||||
| Forward PE Ratio | 14.94 | |||||
| PE Ratio without NRI | 16.44 | |||||
| Shiller PE Ratio | 18.79 | |||||
| Price-to-Owner-Earnings | 24.85 | |||||
| PS Ratio | 1.55 | |||||
| PB Ratio | 2.48 | |||||
| Price-to-Free-Cash-Flow | 18.39 | |||||
| Price-to-Operating-Cash-Flow | 12.72 | |||||
| EV-to-EBIT | 22.11 | |||||
| EV-to-Forward-EBIT | 15.06 | |||||
| EV-to-EBITDA | 14.25 | |||||
| EV-to-Forward-EBITDA | 11.51 | |||||
| EV-to-Revenue | 1.98 | |||||
| EV-to-Forward-Revenue | 1.85 | |||||
| EV-to-FCF | 23.56 | |||||
| Price-to-GF-Value | 0.98 | |||||
| Price-to-Projected-FCF | 0.97 | |||||
| Price-to-Median-PS-Value | 1.09 | |||||
| Earnings Yield (Greenblatt) % | 4.52 | |||||
| FCF Yield % | 5.47 | |||||
| Forward Rate of Return (Yacktman) % | -0.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:LH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Labcorp Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13,008.9 | ||
| EPS (TTM) ($) | 8.82 | ||
| Beta | 0.99 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 18.08 | ||
| 14-Day RSI | 40.69 | ||
| 14-Day ATR ($) | 5.446843 | ||
| 20-Day SMA ($) | 248.1225 | ||
| 12-1 Month Momentum % | 17.93 | ||
| 52-Week Range ($) | 191.97 - 258.59 | ||
| Shares Outstanding (Mil) | 83.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Labcorp Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Labcorp Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Labcorp Holdings Inc Frequently Asked Questions
What is Labcorp Holdings Inc(LH)'s stock price today?
The current price of LH is $239.53. The 52 week high of LH is $258.59 and 52 week low is $191.97.
When is next earnings date of Labcorp Holdings Inc(LH)?
The next earnings date of Labcorp Holdings Inc(LH) is 2025-04-25 Est..
Does Labcorp Holdings Inc(LH) pay dividends? If so, how much?
The Dividend Yield %  of Labcorp Holdings Inc(LH) is 1.2% (As of Today), Highest Dividend Payout Ratio of Labcorp Holdings Inc(LH) was 0.21. The lowest was 0.16. And the median was 0.2. The  Forward Dividend Yield % of Labcorp Holdings Inc(LH) is 1.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers